Plexus Ventures
Plexus
We help companies identify, evaluate, and negotiate in-licensing opportunities to expand their growth potential and geographic presence.
We advise companies in developing an out-licensing strategy and guide them in maximizing the value of their compounds, products, and technologies.
We help firms identify potential product and company acquisitions, develop deal structures, and negotiate definitive agreements.
We are global experts in pharmaceutical divestments, working with companies to target buyers, generate competition for assets, and maximize proceeds.
GLOBAL PRESENCE world

1-888-PLEXUS0 (753-9870)

info@plexusventures.com
RECENT NEWS
  • June 22, 2009 Gerd Meyer Dr. oec. Joins Plexus Ventures as Senior Consultant
  • March 10, 2009 Taisho Pharmaceuticals Appoints Plexus Ventures in Business Development
  • February 13, 2009 Primus Pharmaceuticals Appoints Plexus Ventures in Business Development
  • February 13, 2009 Roger Cox, Ph.D., Former J&J Licensing Executive Joins Plexus Ventures
PharmaTimes World News
  • July 6, 2009Eisai tightens up development and looks to emerging markets
  • July 5, 2009Big Pharma warns Philippines over price curbs
  • July 6, 2009Actelion's Tracleer approved for children in Europe
  • July 6, 2009Oxford BioMedica joy as FDA backs further TroVax development
  • July 6, 2009No increased risk of blindness with Lantus, says Sanofi
Home | About | Services | Track Record | News Room | Contact | Japanese Japanese Language
  • Overview
  • Our Approach
  • Our History
  • Our Team
  • Our Offices
  • Overview
  • In-Licensing
  • Out-Licensing
  • Acquisitions
  • Divestments
  • Overview
  • Case Studies
  • Client List
  • Press Releases
  • Articles & Presentations
  • Media Inquiries